Photosensitizers in clinical PDT

Allison, 1998, Photodynamic therapy for the treatment of nonmelanomatous cutaneous malignancies, Semin Cutan Med Surg, 17, 153, 10.1016/S1085-5629(98)80008-4

Bonnett, 1989, Porphyrins as photosensitizers, Ciba Found Symp, 146, 40

Dougherty TJ, Henderson BW, Schwartz S, et al. Historical perspective. In: Henderson BW, Dougherty TJ, editors. Photodynamic therapy. New York: Marcel Dekker; 1992. p. 1–15.

Finsen NF. Phototherapy. London: Arnold; 1901.

Raab, 1900, On the effect of fluorescent substances on infusoria (in German), Z Biol, 39, 524

Jesionek, 1905, On the treatment of skin cancers with fluorescent substances, Arch Klin Med, 82, 223

Jodlbauer, 1904, On the participation of oxygen in the photodynamic effect of fluorescent substances, Münch Med Wochenschr, 52, 1139

Von Tappeiner, 1904, On the effect of photodynamic (fluorescent) substances on protozoa and enzymes, Arch Klin Med, 80, 427

Schmid R. The porphyrias. In: Stanberg JB, Wyngaarden JB, Fredrickson DB, editors. The metabolic basis of inherited disease. New York: McGraw Hill Book Co; 1966. p. 813–70.

Dougherty, 1978, Photoradiation therapy for the treatment of malignant tumors, Cancer Res, 38, 2628

Drabkin DL. Selected landmarks in the history of porphyrins and their biologically functional derivatives. In: Dolphin D, editor. The porphyrins. Academic Press; 1978. p. 31–84.

Konan, 2002, State of the art in the delivery of photosensitizers for photodynamic therapy, J Photochem Photobiol B, 66, 89, 10.1016/S1011-1344(01)00267-6

Wagnieres, 1998, In vivo fluorescence spectroscopy and imaging for oncological applications, Photochem Photobiol, 68, 603, 10.1111/j.1751-1097.1998.tb02521.x

Gillenwater, 1998, Fluorescence spectroscopy: a technique with potential to improve the early detection of aerodigestive tract neoplasia, Head Neck, 20, 556, 10.1002/(SICI)1097-0347(199809)20:6<556::AID-HED11>3.0.CO;2-O

Svanberg, 1998, Laser-based spectroscopic methods in tissue characterization, Ann N Y Acad Sci, 838, 123, 10.1111/j.1749-6632.1998.tb08193.x

Richards-Kortum, 1996, Quantitative optical spectroscopy for tissue diagnosis, Annu Rev Phys Chem, 47, 555, 10.1146/annurev.physchem.47.1.555

Braichotte, 1996, Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy, Lasers Surg Med, 19, 340, 10.1002/(SICI)1096-9101(1996)19:3<340::AID-LSM10>3.0.CO;2-8

Diamond, 2003, Quantification of fluorophore concentration in tissue-simulating media by fluorescence measurements with a single optical fiber, Appl Opt, 42, 2436, 10.1364/AO.42.002436

Hu XH, Feng Y, Lu JQ, et al. Modeling of type II photodynamic therapy process in a heteregeneous tissue phantom. Phys Med Biol 2004; submitted for publication.

Foster, 1991, Oxygen consumption and diffusion effects in photodynamic therapy, Radiat Res, 126, 296, 10.2307/3577919

Bonnett, 1983, HpD—a study of its components and their properties, Adv Exp Med Biol, 160, 241, 10.1007/978-1-4684-4406-3_21

Mironov, 1990, Haematoporphyrin derivatives: an oligometric composition study, J Photochem Photobiol B: Biol, 4, 297, 10.1016/1011-1344(90)85035-U

Kessel, 1987, Probing the structure and stability of the tumor-localizing derivative of hematoporphyrin by reductive cleavage with LiAlH4, Cancer Res, 47, 4642

Bonnett, 1989, Hydroporphyrins of the meso-tetrahydroxyphenyl porphyrin series as tumors photosensitizers, Biochem J, 261, 277, 10.1042/bj2610277

Winkelman, 1987, Neurotoxicity of tetraphenylporphinesulfonate TPPS4 and its relation to photodynamic therapy, Photochem Photobiol, 46, 801, 10.1111/j.1751-1097.1987.tb04851.x

Lapes, 1996, Photodynamic therapy of cutaneous metastases of breast cancer after local application of meso-tetra-(para-sulphophenyl)-porphin (TPPS4), J Photochem Photobiol B, 36, 205, 10.1016/S1011-1344(96)07373-3

Levy, 1994, Photodynamic therapy of malignancies with benzoporphyrin derivative monoacid ring A, Proc Soc Photo-Opt Instrum Eng, 2078, 99

Kennedy, 1992, Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy, J Photochem Photobiol B, 14, 275, 10.1016/1011-1344(92)85108-7

Hausman, 1907, The photodynamic action of plant extracts containing chlorophyll, Biochem Z, 12, 331

Bonnett, 1995, Photosensitizers of the porphyrin and phthalocyanine photodynamic therapy, Chem Soc Rev, 24, 19, 10.1039/cs9952400019

Bonnett, 1994, New photosensitizers for the photodynamic therapy of tumors, Proc Soc Photo-Opt Instrum Eng, 2078, 74

Roberts, 1988, In vitro characterization of monoaspartylchlorin e6 for photodynamic therapy, J Natl Cancer Inst, 80, 330, 10.1093/jnci/80.5.330

Allen R, Kessel D, Tharratt RS, et al. Photodynamic therapy of superficial malignancies with NPe6 in man. In: Spinelli P, DalFante M, Marchese R, editors. Photodynamic therapy and biomedical lasers. New York: Elsevier Science; 1992. p. 441–5.

Morgan, 1988, New photosensitizers for photodynamic therapy: combined effect of metallopurpurin derivatives and light on transplantable bladder tumors, Cancer Res, 48, 194

Moser, 1993, Bacteriopheophorbide ester as a sensitizer, SPIE, 1881, 116, 10.1117/12.146301

Stradnadko, 1997, Photodynamic therapy of cancer: five year clinical experience, Proc Soc Photo-Opt Instrum Eng, 3191, 253

Moser JG. 2nd and 3rd generation photosensitizers. Amsterdam: Harwood Academic Publishers; 1998.

Dougherty, 1987, Studies on the structure of porphyrins contained in Photofrin II, Photochem Photobiol, 46, 569, 10.1111/j.1751-1097.1987.tb04815.x

Dougherty, 1993, Photodynamic therapy, Photochem Photobiol, 58, 895, 10.1111/j.1751-1097.1993.tb04990.x

Dougherty, 1998, Photodynamic therapy, J Natl Cancer Inst, 90, 889, 10.1093/jnci/90.12.889

Sibata, 2000, Photodynamic therapy: a new concept in medical treatment, Braz J Med Biol Res, 33, 869, 10.1590/S0100-879X2000000800002

Bernstein, 1999, Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi’s sarcoma, AIDS, 13, 1697, 10.1097/00002030-199909100-00013

Jones, 1992, Photodynamic therapy in the treatment of Bowen’s disease, J Am Acad Dermatol, 27, 979, 10.1016/0190-9622(92)70298-T

Taber, 1998, Photodynamic therapy for palliation of chest wall recurrence in patients with breast cancer, J Surg Oncol, 68, 209, 10.1002/(SICI)1096-9098(199808)68:4<209::AID-JSO2>3.0.CO;2-8

Allison, 2001, Photodynamic therapy for chest wall progression from breast carcinoma is an underutilized treatment modality, Cancer, 91, 1, 10.1002/1097-0142(20010101)91:1<1::AID-CNCR1>3.0.CO;2-P

Moghissi, 1999, The place of bronchoscopic photodynamic therapy in advanced unresectable lung cancer: experience of 100 cases, Eur J Cardiothorac Surg, 15, 1, 10.1016/S1010-7940(98)00295-4

Moghissi, 1997, Endoscopic laser therapy in malignant tracheobronchial obstruction using sequential Nd YAG laser and photodynamic therapy, Thorax, 52, 281, 10.1136/thx.52.3.281

Kato, 1997, Photodynamic therapy for bronchogenic carcinoma, Nippon Geka Gakkai Zasshi, 98, 36

Cortese, 1997, Photodynamic therapy for early stage squamous cell carcinoma of the lung, Mayo Clin Proc, 72, 595, 10.1016/S0025-6196(11)63563-5

Pass, 1997, Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma, Ann Surg Oncol, 4, 628, 10.1007/BF02303746

Savary, 1998, Photodynamic therapy of early squamous cell carcinomas of the esophagus: a review of 31 cases, Endoscopy, 30, 258, 10.1055/s-2007-1001252

Grosjean, 1998, Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514nm compared with 630 nm light irradiation after sensitization with Photofrin II, Br J Cancer, 77, 1989, 10.1038/bjc.1998.330

Lightdale, 1995, Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd: YAG laser for palliation of esophageal cancer: a multicenter randomized trial, Gastrointest Endosc, 42, 507, 10.1016/S0016-5107(95)70002-1

Overholt, 2000, Photodynamic therapy in the management of Barrett’s esophagus with dysplasia, J Gastrointest Surg, 4, 129, 10.1016/S1091-255X(00)80047-5

Panjehpour, 2000, Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett’s esophagus and effect of oral steroids on stricture formation, Am J Gastroenterol, 95, 2177, 10.1111/j.1572-0241.2000.02300.x

Overholt, 1996, Photodynamic therapy in Barrett’s esophagus, J Clin Laser Med Surg, 14, 245, 10.1089/clm.1996.14.245

Overholt, 1999, Photodynamic therapy for Barrett’s esophagus: follow-up in 100 patients, Gastrointest Endosc, 49, 1, 10.1016/S0016-5107(99)70437-2

Runfola, 2000, Photodynamic therapy for residual neoplasms of the perianal skin, Dis Colon Rectum, 43, 499, 10.1007/BF02237193

Loh, 1994, Photodynamic therapy for villous adenomas of the colon and rectum, Endoscopy, 26, 243, 10.1055/s-2007-1008952

Kostron, 1996, Photodynamic therapy in neurosurgery: a review, J Photochem Photobiol B, 36, 157, 10.1016/S1011-1344(96)07364-2

Muller, 1995, Photodynamic therapy for recurrent supratentorial gliomas, Semin Surg Oncol, 11, 346, 10.1002/ssu.2980110504

Popovic, 1996, Photodynamic therapy of brain tumors, J Clin Laser Med Surg, 14, 251, 10.1089/clm.1996.14.251

Biel, 1998, Photodynamic therapy and the treatment of head and neck neoplasia, Laryngoscope, 108, 1259, 10.1097/00005537-199809000-00001

Nseyo, 1998, Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: a long-term experience, J Clin Laser Med Surg, 16, 61, 10.1089/clm.1998.16.61

Cuenca R, Allison R, Downie G, et al. Breast cancer with chest wall progression: treating with photodynamic therapy. Ann Surg Oncol 2004; in press.

Peng, 1997, 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges, Cancer, 79, 2282, 10.1002/(SICI)1097-0142(19970615)79:12<2282::AID-CNCR2>3.0.CO;2-O

Loh, 1993, Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy, Br J Cancer, 68, 41, 10.1038/bjc.1993.284

Peng, 1997, 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research, Photochem Photobiol, 65, 235, 10.1111/j.1751-1097.1997.tb08549.x

Wang, 2001, Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial, Br J Dermatol, 144, 832, 10.1046/j.1365-2133.2001.04141.x

Morton, 2001, Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma, Arch Dermatol, 137, 319

Grant, 1993, Photodynamic therapy of oral cancer: photosensitization with systemic aminolevulinic acid, Lancet, 342, 147, 10.1016/0140-6736(93)91347-O

Fan, 1996, Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity, Cancer, 78, 1374, 10.1002/(SICI)1097-0142(19961001)78:7<1374::AID-CNCR2>3.0.CO;2-L

Kriegmair, 1994, Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?, Urologe A, 33, 276

Waidelich, 2003, Whole bladder PDT with 5-ALA and a white light source, Urology, 61, 332, 10.1016/S0090-4295(02)02164-7

Freeman, 2003, A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study, J Dermatolog Treat, 14, 99, 10.1080/09546630310012118

Pariser, 2003, Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial, J Am Acad Dermatol, 48, 227, 10.1067/mjd.2003.49

Ca, 2003, Methyl aminolevulinate (Metvix) photodynamic therapy—practical pearls, J Dermatolog Treat, 14, 23

Lange, 1999, Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study, Br J Cancer, 80, 185, 10.1038/sj.bjc.6690338

Jichlinski, 2003, Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer—a multicenter study, J Urol, 170, 226, 10.1097/01.ju.0000060782.52358.04

Gossner, 1995, Photodynamic therapy: successful destruction of gastrointestinal cancer after oral administration of aminolevulinic acid, Gastrointest Endosc, 41, 55, 10.1016/S0016-5107(95)70276-8

Mlkvy, 1995, Sensitization and photodynamic therapy (PDT) of gastrointestinal tumors with 5-aminolaevulinic acid (ALA) induced protoporphyrin IX (PPIX). A pilot study, Neoplasma, 42, 109

Ackroyd, 2003, Eradication of dysplastic Barrett’s oesophagus using photodynamic therapy: long-term follow-up, Endoscopy, 35, 496, 10.1055/s-2003-39676

Ortner, 2002, Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett’s esophagus? A pilot study, Endoscopy, 34, 611, 10.1055/s-2002-33247

Regula, 1995, Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX—a pilot study, Gut, 36, 67, 10.1136/gut.36.1.67

Houle, 2002, Clinical pharmacokinetics of verteporfin, J Clin Pharmacol, 42, 547, 10.1177/00912700222011607

Houle, 2002, Duration of skin photosensitivity and incidence of photosensitivity reactions after administration of verteporfin, Retina, 22, 691, 10.1097/00006982-200212000-00002

Leung, 1994, Photosensitizers in photodynamic therapy, Semin Oncol, 21, 4

Richter, 1987, Preliminary studies on a more effective phototoxic agent than hematoporphyrin, J Natl Cancer Inst, 79, 1327

Gragoudas, 1997, Results and preliminary dosimetry of photodynamic therapy for choroidal neovascularization in age-related macular degeneration in a phase I/II study, Assoc Res Vision Opthamol, 38, 73

Blinder, 2003, Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial—VIP report no. 3, Ophthalmology, 110, 667, 10.1016/S0161-6420(02)01998-X

Young, 1996, Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative, Arch Ophthalmol, 114, 186, 10.1001/archopht.1996.01100130180013

Barbazetto, 2003, Treatment of choroidal melanoma using photodynamic therapy, Am J Ophthalmol, 135, 898, 10.1016/S0002-9394(02)02222-5

Lui, 1994, Photodynamic therapy in dermatology with porfimer sodium and benzoporphyrin derivative: an update, Semin Oncol, 21, 11

Sessler, 2000, Texaphyrins: new drugs with diverse clinical applications in radiation and photodynamic therapy, Biochem Pharmacol, 59, 733, 10.1016/S0006-2952(99)00314-7

Young, 1996, Lutetium texaphyrin (PCI-0123): a near-infrared, water-soluble photosensitizer, Photochem Photobiol, 63, 892, 10.1111/j.1751-1097.1996.tb09647.x

Sessler, 1994, Texaphyrins: synthesis and applications, Acc Chem Res, 27, 43, 10.1021/ar00038a002

Young, 1996, Lutetium texaphyrin (PCI-0123): a near-infrared, water-soluble photosensitizer, Photochem Photobiol, 63, 892, 10.1111/j.1751-1097.1996.tb09647.x

Carde, 2001, Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases, J Clin Oncol, 19, 2074, 10.1200/JCO.2001.19.7.2074

Renschler MF, Yuen A, Panella TJ, et al. Photodynamic therapy trials with lutetium texaphyrin PCI-0123 (Lu-Tex). In: 25th Annual Meeting for Photobiology. St. Louis, MO: The American Society for Photobiology; 1997.

Renschler, 1998, Photodynamic therapy trials with lutetium texaphyrin (Lu-Tex) in patients with locally recurrent breast cancer, Proc Soc Photo-Opt Instrum Eng, 3247, 35

Dimofte, 2002, In vivo light dosimetry for motexafin lutetium-mediated PDT of recurrent breast cancer, Lasers Surg Med, 31, 305, 10.1002/lsm.10115

Rockson, 2000, Photoangioplasty for human peripheral atherosclerosis: results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin), Circulation, 102, 2322, 10.1161/01.CIR.102.19.2322

Kereiakes, 2003, Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: procedural and long-term results, Circulation, 108, 1310, 10.1161/01.CIR.0000087602.91755.19

Renschler, 1997, Photodynamic therapy trials with lutetium texaphyrin, Photochem Photobiol, 65, 475

Berenbaum, 1993, Selectivity of meso-tetra(hydroxyphenyl) porphyrins and chlorins and of Photofrin II in causing photodamage in tumor, skin, Lasers Med Sci, 8, 235, 10.1007/BF02547845

Glanzmann, 1998, Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy, Photochem Photobiol, 67, 596, 10.1111/j.1751-1097.1998.tb09099.x

Kubler, 1999, Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck, Lasers Surg Med, 25, 60, 10.1002/(SICI)1096-9101(1999)25:1<60::AID-LSM8>3.0.CO;2-X

Baas, 2001, Photodynamic therapy with meta-tetrahydroxyphenylchlorin for basal cell carcinoma: a phase I/II study, Br J Dermatol, 145, 75, 10.1046/j.1365-2133.2001.04284.x

Kubler, 2001, Treatment of squamous cell carcinoma of the lip using Foscan-mediated photodynamic therapy, Int J Oral Maxillofac Surg, 30, 504, 10.1054/ijom.2001.0160

Grosjean, 1996, Photodynamic therapy for cancer of the upper aerodigestive tract using tetra(m-hydroxyphenyl)chlorin, J Clin Laser Med Surg, 14, 281, 10.1089/clm.1996.14.281

Friedberg, 2003, A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma, Ann Thorac Surg, 75, 952, 10.1016/S0003-4975(02)04474-0

Schouwink, 2001, Intraoperative photodynamic therapy after pleuropneumonectomy in patients with malignant pleural mesothelioma: dose finding and toxicity results, Chest, 120, 1167, 10.1378/chest.120.4.1167

Ris, 1996, Intraoperative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies, Lasers Surg Med, 18, 39, 10.1002/(SICI)1096-9101(1996)18:1<39::AID-LSM5>3.0.CO;2-S

Savary, 1997, Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin, Arch Otolaryngol Head Neck Surg, 123, 162, 10.1001/archotol.1997.01900020042006

Etienne, 2000, Local curative treatment of superficial adenocarcinoma in Barrett’s esophagus. First results of photodynamic therapy with a new photosensitizer, Bull Acad Natl Med, 184, 1731

Ell, 1998, Photodynamic ablation of early cancers of the stomach by means of mTHPC and laser irradiation: preliminary clinical experience, Gut, 43, 345, 10.1136/gut.43.3.345

Mlkvy, 1996, Distribution and photodynamic effects of meso-tetrahydroxyphenylchlorin (mTHPC) in the pancreas and adjacent tissues in the Syrian golden hamster, Br J Cancer, 73, 1473, 10.1038/bjc.1996.279

Bown, 2002, Photodynamic therapy for cancer of the pancreas, Gut, 50, 549, 10.1136/gut.50.4.549

Dilkes, 2003, Treatment of primary mucosal head and neck squamous cell carcinoma using photodynamic therapy: results after 25 treated cases, J Laryngol Otol, 117, 713, 10.1258/002221503322334558

Fan, 1997, Photodynamic therapy using mTHPC for malignant disease in the oral cavity, Int J Cancer, 73, 25, 10.1002/(SICI)1097-0215(19970926)73:1<25::AID-IJC5>3.0.CO;2-3

Wenig B, D’Cruz A, Iqbal A, et al. Foscan-mediated photodynamic therapy in the palliative treatment of advanced head and neck cancer. In: Proceedings of the 39th American Society of Clinical Oncology. 2000.

Hornung, 1998, Uptake of the photosensitizer benzoporphyrin derivative in human endometrium after topical application in vivo, J Am Assoc Gynecol Laparosc, 5, 367, 10.1016/S1074-3804(98)80049-2

Suhr, 2001, Clinical pilot study of interstitial photodynamic therapy for treatment of advanced head and neck tumors, Mund Kiefer Gesichtschir, 5, 277, 10.1007/s100060100325

Copper, 2003, Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck, Arch Otolaryngol Head Neck Surg, 129, 709, 10.1001/archotol.129.7.709

Wyss, 2001, Photodynamic therapy of locoregional breast cancer recurrences using a chlorin-type photosensitizer, Int J Cancer, 93, 720, 10.1002/ijc.1400

Patterson MS, Wilson BC. Photodynamic therapy. In: Dyh JV, editor. The modern technology of radiation oncology. Madison: Medical Physics Publishing; 1999. p. 941–80.

Grekin R, Razun N, Trommer R, et al. Tin ethyl etiopurpurin (SnET2) photodynamic therapy (PDT): results of a phase I/II clinical study conduced at UCSF for the treatment of AIDS-associted cutaneous Kaposi’s sarcomas. In: International Conference on AIDS. 1996.

Mang, 1998, A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer, Cancer J Sci Am, 4, 378

Kaplan, 1998, Photodynamic therapy in the management of metastatic cutaneous adenocarcinomas: case reports from phase 1/2 studies using tin ethyl etiopurpurin (SnET2), J Surg Oncol, 67, 121, 10.1002/(SICI)1096-9098(199802)67:2<121::AID-JSO9>3.0.CO;2-C

Razum, 1996, SnET2: clinical update, Proc Soc Photo-Opt Instrum Eng, 2675, 43

Spikes, 1990, Chlorins as photosensitizers in biology and medicine, J Photochem Photobiol B, 6, 259, 10.1016/1011-1344(90)85096-F

Kreimer-Birnbaum, 1989, Modified porphyrins, chlorins, phthalocyanines, and purpurins: second-generation photosensitizers for photodynamic therapy, Semin Hematol, 26, 157

Taber SW, Fingar VH, Coots CT, et al. Photodynamic therapy using mono-l-aspartyl chlorin e6 (NPe6) for the treatment of cutaneous disease: a phase I clinical study. Clin Cancer Res 1998;4(11):2741–6.

Lim JI. Photodynamic therapy for choroidal neovascular disease: photosensitizers and clinical trials. Ophthalmol Clin North Am 2002;15(4):473–8.

Furukawa, 1998, A Phase I clinical study of photodynamic therapy of early stage lung carcinoma using ME2906 and a diode laser system, Porphyrins, 7, 199

Lustig, 2003, A multicenter Phase I safety study of intratumoral photoactivation of talaporfin sodium in patients with refractory solid tumors, Cancer, 98, 1767, 10.1002/cncr.11708

Pandey, 1991, Chlorin and porphyrin derivatives as potential photosensitizers in photodynamic therapy, Photochem Photobiol, 53, 65, 10.1111/j.1751-1097.1991.tb08468.x

Magne, 1997, Photodynamic therapy of facial squamous cell carcinoma in cats using a new photosensitizer, Lasers Surg Med, 20, 202, 10.1002/(SICI)1096-9101(1997)20:2<202::AID-LSM12>3.0.CO;2-H

McCaw, 2000, Treatment of canine oral squamous cell carcinomas with photodynamic therapy, Br J Cancer, 82, 1297, 10.1054/bjoc.1999.1094

Bellnier, 2003, Population pharmacokinetics of the photodynamic therapy agent 2- [1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients, Cancer Res, 63, 1806

Ben-Hur, 1985, The Phthalocyanines: a new class of mammalian cells photosensitizers with a potential for cancer phototherapy, Int J Radiat Biol Relat Stud Phys Chem Med, 47, 145, 10.1080/09553008514550211

Allen, 2001, Current Status of phthalocyanines in the photodynamic therapy of cancer, J Porphyrins Phthalocyanines, 5, 161, 10.1002/jpp.324

Peaston, 1993, Photodynamic therapy for nasal and aural squamous cell carcinoma in cats, J Am Vet Med Assoc, 202, 1261, 10.2460/javma.1993.202.08.1261

van Leengoed, 1991, Tumour tissue imaging using the localizing properties and fluorescence of some phthalocyanines, Int J Radiat Biol, 60, 121, 10.1080/09553009114551691

Uspenskii, 2000, Endobronchial laser therapy in complex preoperative preparation of patients with lung diseases, Khirurgiia (Mosk), 2, 38

Sokolov, 1995, The photodynamic therapy of malignant tumors in basic sites with the preparations photohem and photosens (the results of 3 years of observations), Vopr Onkol, 41, 134

Stranadko, 2001, Photodynamic therapy of recurrent and residual oropharyngeal and laryngeal tumors, Vestn. Otorinolaringol, 3, 36

Ben-Hur, 1988, Combined action of phthalocyanine photosensitization and gamma-radiation on mammalian cells, Int J Radiat Biol, 54, 21, 10.1080/09553008814551471